3 Results for "

Vimirogant

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Vimirogant" in MCE Product Catalog:

Cat. No.: HY-103637
CAS No.: 1802706-04-2
Synonyms: VTP-43742
Target:  

ROR Interleukin Related

Research Areas:  

Inflammation/Immunology

Vimirogant (VTP-43742) is a potent, selective, and orally active RORγt inhibitor with a Ki of 3.5 nM for binding to RORγt. VTP-43742 blocks Th17 cell differentiation and reduces IL-17A production by inhibiting RORγt-mediated transcriptional activity, thereby suppressing the RORγt/Th17/IL-17 inflammatory axis. VTP-43742 can be used for research on autoimmune diseases and inflammation-related diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103637A
CAS No.: 1802678-42-7
Purity:  98.39%
Synonyms: VTP-43742 hydrochloride
Target:  

ROR Interleukin Related

Research Areas:  

Inflammation/Immunology

Vimirogant hydrochloride (VTP-43742 hydrochloride) is a potent, selective, and orally active RORγt inhibitor with a Ki of 3.5 nM for binding to RORγt. VTP-43742 blocks Th17 cell differentiation and reduces IL-17A production by inhibiting RORγt-mediated transcriptional activity, thereby suppressing the RORγt/Th17/IL-17 inflammatory axis. VTP-43742 can be used for research on autoimmune diseases and inflammation-related diseases .
loading...
    loading...
Cat. No.: HY-103637B
CAS No.: 2115761-82-3
Synonyms: VTP-43742 hydrobromide
Target:  

ROR Interleukin Related

Research Areas:  

Inflammation/Immunology

Vimirogant hydrobromide (VTP-43742 hydrobromide) is a potent, selective, and orally active RORγt inhibitor with a Ki of 3.5 nM for binding to RORγt. VTP-43742 blocks Th17 cell differentiation and reduces IL-17A production by inhibiting RORγt-mediated transcriptional activity, thereby suppressing the RORγt/Th17/IL-17 inflammatory axis. VTP-43742 can be used for research on autoimmune diseases and inflammation-related diseases .
loading...
    loading...